Olufunmilayo I. Olopade born in the year 1957, is a Nigerian hematology oncologist, Associate Dean for Global Health and Walter L. Palmer, Distinguished Service Professor in Medicine and Human Genetics at the University of Chicago. She also serves as director of the University of Chicago Hospital's Cancer Risk Clinic.
Sir Bruce Anthony John Ponder FMedSci FAACR FRS FRCP is an English geneticist and cancer researcher. He is Emeritus Professor of Oncology at the University of Cambridge and former director of the Cancer Research UK Cambridge Institute and of the Cancer Research UK Cambridge Cancer Centre.
Anthony Peter Lowe AP is a British-Australian mathematical physicist and actuary. He previously served as chief executive officer of the Prostate Cancer Foundation of Australia, and is a frequent media commentator on prostate cancer and prostate specific antigen (PSA) testing.
Pamela J. Russell was an Australian academic researcher of immunology, bladder and prostate research. Russell was awarded Membership of the Order of Australia (AM) for her research on prostate and bladder cancer in 2003.
Gail Garvey is an Indigenous Australian Health Services Research with a core focus on Psycho-oncology and Indigenous people. Garvey is a Kamilaroi woman whose family originated from Moree in western New South Wales. She was a professor at the Menzies School of Health, and served as a Senior Principal Research Fellow and Deputy Division Leader for the Wellbeing and Preventable Chronic Diseases Division. She was recently appointed as a Professor at the University of Queensland, Darwin
Vanessa Hayes is a geneticist conducting research into cancer genomics and comparative human genomics. She leads a research group at the Garvan Institute of Medical Research in Sydney Australia and holds the Petre Chair of Prostate Cancer Research at the University of Sydney.
David John Hunter is an Australian epidemiologist and the Richard Doll Professor of Epidemiology and Medicine at Oxford Population Health. He was previously a professor in Harvard University's departments of Epidemiology and Nutrition. Hunter was associate epidemiologist, Channing Laboratory, Brigham and Women's Hospital, where he was involved with the programs in breast cancer, cancer epidemiology, and cancer genetics research teams. At Oxford he directs the Translational Epidemiology Unit and leads a collaborative project between Oxford and the Harvard T.H. Chan School of Public Health.
Nilanjan Chatterjee is a Bloomberg Distinguished Professor of Biostatistics and Genetic Epidemiology at Johns Hopkins University, with appointments in the Department of Biostatistics in the Bloomberg School of Public Health and in the Department of Oncology in the Sidney Kimmel Comprehensive Cancer Center in the Johns Hopkins School of Medicine. He was formerly the chief of the Biostatistics Branch of the National Cancer Institute's Division of Cancer Epidemiology and Genetics.
Elaine Ann Ostrander is an American geneticist at the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH) in Bethesda, Maryland. She holds a number of professional academic appointments, currently serving as Distinguished and Senior Investigator and head of the NHGRI Section of Comparative Genomics; and Chief of the Cancer Genetics and Comparative Genomics Branch. She is known for her research on prostate cancer susceptibility in humans and for conducting genetic investigations with the Canis familiaris —the domestic dog— model, which she has used to study disease susceptibility and frequency and other aspects of natural variation across mammals. In 2007, her laboratory showed that much of the variation in body size of domestic dogs is due to sequence changes in a single gene encoding a growth-promoting protein.
Professor Dame Lesley Jean Fallowfield DBE is a British cancer psychologist and a professor of psycho-oncology at the University of Sussex. The main outcomes of her research have been the establishment of assessment tools to measure quality of life in clinical trials of cancer patients and the design of educational programmes to improve oncologists' communication with their patients.
Rosalind Anne Eeles is a Professor of Oncogenetics at the Institute of Cancer Research and clinician at the Royal Marsden NHS Foundation Trust. She is a leader in the field of genetic susceptibility to prostate cancer, and is known for the discovery of 14 genetic variants involved in prostate cancer predisposition. According to ResearchGate, Eeles has published more than 500 articles in peer-reviewed journals, with over 34,000 citations and an h-index of 92. Eeles was elected a Fellow of the Academy of Medical Science in 2012. She was awarded a National Institute for Health Research Senior Investigator Emeritus in 2014.
Joan Ellen Bailey-Wilson is an American statistical geneticist. She is a senior investigator and co-chief of the Computational and Statistical Genomic Branch of the National Human Genome Research Institute.
Bettina Meiser is a professor at the University of New South Wales, with expertise in the psychosocial aspects of genetics; cancer, hereditary cancer, and the impact of genetic counselling and testing.
Jennifer Anne Byrne is a Professor of Molecular Oncology at University of Sydney, Australia. Byrne is notable for not only her cancer research, but the uncovering of academic fraud and junk science in cancer research.
Deborah Watkins Bruner is an American researcher, clinical trialist, and academic. She is the senior vice president for research at Emory University. Her research focus is on patient reported outcomes, symptom management across cancer sites, sexuality after cancer treatment, and effectiveness of radiotherapy modalities. Bruner's research has been continually funding since 1998, with total funding of her research exceeding $180 million. She is ranked among the top five percent of all National Institutes of Health-funded investigators worldwide since 2012, according to the Blue Ridge Institute for Medical Research.
Wendy Rosamund Brewster was a British-born American gynaecologist who was Professor of Obstetrics and Gynaecology and Director of the Center for Women's Health Research at the University of North Carolina at Chapel Hill.
Folakemi Titilayo Odedina is a Nigerian-born scientist and professor of pharmacy and medicine at the University of Florida. She is the principal investigator for the Prostate Cancer Transatlantic Consortium (CaPTC), a clinical research group using genomic science and environmental etiology to exploring disproportionate burden of prostate cancer among Black men funded by the NCI. She is a member of American Cancer Society's National Prostate Cancer Disparities Advisory Team.
Mark Emberton is a urologist and prostate cancer research specialist using novel imaging techniques and minimally invasive treatments to improve diagnosis and treatment of prostate cancer.
Lyn Robyn Griffiths is an Australian academic who serves as Distinguished Professor of molecular genetics at Queensland University of Technology, where she is director of the Centre for Genomics and Personalised Health, the Genomics Research Centre and the BridgeTech Programs. Griffiths is internationally renowned for her work in the discovery of the genetics of migraine headaches.
Patsy Yates is an Australian registered nurse, university professor, and institutional leader who works at the Queensland University of Technology (Brisbane), where she is a Distinguished Professor and Executive Dean of the Faculty of Health, Research Director of the Centre for Palliative Care Research and Education, and Co-Director of the Centre for Healthcare Transformation. She is a specialist in the field of palliative, cancer and aged care.
